Kariv Tomer Insider Trades

Insider Trading History

Track insider trading activity for Kariv Tomer. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Keros Therapeutics
Keros Therapeutics KROS
10% owner
Holding Value $116k 10,500 shares
Last Trade
Jun 04, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$156k 10,500 shares
$14.82
$11.03
Keros Therapeutics
Keros Therapeutics KROS
10% owner
Holding Value $110k 10,000 shares
Last Trade
May 30, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$463k 10,000 shares
$46.31
$11.03
Keros Therapeutics
Keros Therapeutics KROS
10% owner
Holding Value $110k 10,000 shares
Last Trade
Jun 06, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$488k 10,000 shares
$48.79
$11.03
Eloxx Pharmaceuticals
Eloxx Pharmaceuticals ELOX
Director
Holding Value $36k 2,859 shares
Last Trade
Jan 30, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$11.4k 2,859 shares
$4.00
$12.59
Keros Therapeutics
Keros Therapeutics KROS
Director
Holding Value $25.2M 2,284,612 shares
Last Trade
Nov 29, 2022 Sale (In The Money)Reported as In The Money on SEC Form 4.
$432k 9,090 shares
$47.57
$11.03
Eloxx Pharmaceuticals
Eloxx Pharmaceuticals ELOX
Director
Holding Value $252k 20,000 shares
Last Trade
Jun 15, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$204k 20,000 shares
$10.20
$12.59
Keros Therapeutics
Keros Therapeutics KROS
10% owner
Holding Value $91.5k 8,293 shares
Last Trade
Jun 01, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$547k 16,586 shares
$32.95
$11.03
Keros Therapeutics
Keros Therapeutics KROS
10% owner
Holding Value $91.5k 8,293 shares
Last Trade
Jun 01, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$427k 8,293 shares
$51.48
$11.03
Eloxx Pharmaceuticals
Eloxx Pharmaceuticals ELOX
Director
Holding Value $252k 20,000 shares
Last Trade
May 19, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.18M 20,000 shares
$59.20
$12.59
Eloxx Pharmaceuticals
Eloxx Pharmaceuticals ELOX
Director
Holding Value $46.3M 3,679,797 shares
Last Trade
May 13, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$403M 5,925,925 shares
$68.00
$12.59
Keros Therapeutics
Keros Therapeutics KROS
10% owner
Holding Value $25.2M 2,288,151 shares
Last Trade
Nov 17, 2020 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$4.01M 60,000 shares
$66.78
$11.03
Eloxx Pharmaceuticals
Eloxx Pharmaceuticals ELOX
Director
Holding Value $252k 20,000 shares
Last Trade
May 20, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.71M 20,000 shares
$135.60
$12.59
Keros Therapeutics
Keros Therapeutics KROS
10% owner
Holding Value $0 0 shares
Last Trade
Apr 13, 2020 Sale (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$19.6M 842,738 shares
$23.23
$11.03
Keros Therapeutics
Keros Therapeutics KROS
10% owner
Holding Value $24.9M 2,261,517 shares
Last Trade
Apr 13, 2020 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$10.2M 437,499 shares
$23.23
$11.03
Keros Therapeutics
Keros Therapeutics KROS
10% owner
Holding Value $22.8M 2,067,314 shares
Last Trade
Apr 13, 2020 Purchase (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$82.4M 3,545,100 shares
$23.23
$11.03
Keros Therapeutics
Keros Therapeutics KROS
Director
Holding Value $0 0 shares
Last Trade
Apr 07, 2020 Sale
No data
No data
$11.03
Keros Therapeutics
Keros Therapeutics KROS
10% owner
Holding Value $4.09M 370,853 shares
Last Trade
Apr 07, 2020 Sale
No data
No data
$11.03
ContextLogic
ContextLogic LOGC
Director
Holding Value $98.9k 10,869 shares
Last Trade
Dec 19, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$84.1k 10,869 shares
$7.74
$9.10
89bio
89bio ETNB
10% owner
Holding Value $0 0 shares
Last Trade
Nov 13, 2019 Sale (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$113M 5,500,001 shares
$20.50
$14.84
89bio
89bio ETNB
10% owner
Holding Value $16.8M 1,134,671 shares
Last Trade
Nov 13, 2019 Purchase (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$18.1M 884,671 shares
$20.50
$14.84

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up